Atai Life Sciences N.V. (ATAI) Advances Psychedelic Therapies for Mental Health, Drawing Investor Spotlight
Atai Life Sciences N.V.
Atai Beckley N.v. (ATAI)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Adage Capital Management Phill Gross And Robert Atchinson | 5,434,782 | $28,749,997 | 0.05% | |
| 2. | Citadel Investment Group Ken Griffin | 2,575,994 | $13,627,008 | +119% | 0% |
| 3. | ARK Investment Management Catherine D. Wood | 2,019,551 | $10,683,425 | 0.06% | |
| 4. | Millennium Management Israel Englander | 1,097,768 | $5,807,193 | -8% | 0% |
| 5. | Pale Fire Capital Dusan Senkypl, David Holy, And Jan Barta | 1,080,768 | $5,717,263 | -60% | 0.63% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.19 | 8,675,799 | $18,999,999.81 | 51,045,214 | 2025-08-14 | Filing | |
| $1.40 | 1,800,000 | $2,520,000.00 | 42,369,415 | 2025-03-24 | Filing | |
| $2.10 | 10,835,718 | $22,755,007.80 | 40,555,215 | 2025-02-14 | Filing | |
| $1.16 | 20,000 | $23,120.00 | 130,000 | 2023-11-16 | Filing | |
| $1.45 | 40,000 | $57,968.00 | 110,000 | 2023-09-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.35 | 48,563 | $65,560.05 | 115,636 | 2025-03-21 | Filing | |
| $1.35 | 11,563 | $15,610.05 | 8,437 | 2025-03-21 | Filing | |
| $1.35 | 75,418 | $101,814.30 | 212,942 | 2025-03-21 | Filing | |
| $1.35 | 33,545 | $45,285.75 | 140,045 | 2025-03-21 | Filing | |
| $1.35 | 13,161 | $17,767.35 | 42,333 | 2025-03-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 7,677,289 | $40,612,859 | 0.01% | |
| 2. | 4,815,563 | $25,474,332 | 0% | |
| 3. | 2,287,005 | $12,098,256 | 7.37% | |
| 4. | 769,600 | $4,071,183 | 0% | |
| 5. | 718,500 | $3,800,865 | 2.25% |
News See All
15 Best Biotech Penny Stocks to Invest in Right Now
Jared Holz, the healthcare strategist for Mizuho, spoke on CNBC's "Closing Bell Overtime" in July on whether the biotech industry is ready for a breakthrough.
H.C. Wainwright Affirms ‘Buy’ Rating on Atai Life Sciences N.V. (ATAI) on Psychedelic Prospects
Atai Life Sciences N.V. (NASDAQ:ATAI) is one of the best healthcare penny stocks to buy now. On September 15, H.C. Wainwright reiterated a ‘Buy’ rating on the stock and a $15 price target.
11 Best Healthcare Penny Stocks to Buy Now
The US healthcare sector is one of the biggest in the world, with spending expected to reach $5.3 trillion this year.
13 Best Psychedelic Stocks to Invest in Now
Unlike drugs such as cocaine or marijuana, psychedelics create an “alternate reality” by altering feelings, thoughts, and energy levels.
H.C. Wainwright Reiterates a Buy Rating on Atai Life Sciences (ATAI)
Atai Life Sciences (NASDAQ:ATAI) is one of the top strong buy stocks under $5 to buy now. Analyst Patrick Trucchio from H.C.
15 Strong Buy Stocks Under $5 to Buy Now
On August 22, Tom Lee, head of research and chief investment officer of Fundstrat Capital, appeared on CNBC’s ‘Squawk on the Street’ to talk about what he thinks about Fed Chair Powell’s speech...
ATAI Life Sciences (ATAI) Rated as ‘Outperform’ at Oppenheimer on Psychedelic Prospects
Atai Life Sciences (NASDAQ:ATAI) is one of the best multibagger penny stocks to buy according to analysts.
13 Best Multibagger Penny Stocks to Buy According to Analysts
It’s time to pivot towards micro and small-cap stocks as the US Federal Reserve prepares to cut interest rates.